About PapEasy
About PapEasy
PapEasy is a medical device innovation company focused on modernizing cervical cancer screening through women-centered design, improved accessibility, and comprehensive screening program development.We believe screening should not remain limited by outdated methods, discomfort, geography, provider shortages, or unequal access. PapEasy is building toward a broader future that includes more flexible modalities, digital tools, collaborative lab and program partnerships, and scalable infrastructure for the next generation of women’s health innovation.
What We’re Made of and What We’ve Made
Founded in 2020, PapEasy was created with the goal of helping eradicate cervical cancer, a preventable and treatable disease that still claims the lives of nearly half a million women globally each year. With a bold mission and a team of global experts, the company is focused on transforming how women access preventive screening through simple, accessible, and technology-driven solutions. Read More Preview modal-
PapEasy delivers a preventative healthcare device designed for ease of use, incorporating artificial intelligence to continuously improve the user experience in real time. By prioritizing privacy, accessibility, speed, and cultural relevance, the platform enables women to self-screen-or be screened by healthcare professionals-more comfortably, efficiently, and frequently. The broader vision is to support a global movement aimed at reducing cervical cancer mortality through an end-to-end, user-friendly solution. PapEasy also extends its functionality as a multipurpose testing system, supporting additional screenings such as STD and HPV tests within a single integrated package.
Key Highlights
Founded in 2020 with a mission to reduce cervical cancer mortality worldwide.
Focus on eliminating a preventable disease affecting nearly 500,000 women annually.
Global team of medical and technology experts driving innovation.
AI-powered device that improves user experience in real time.
Designed for privacy, accessibility, speed, and cultural adaptability.
Enables comfortable self-screening or practitioner-assisted screening.
Supports more frequent and convenient preventive health testing.
Multipurpose platform capable of facilitating STD and HPV testing in one system.
End-to-end solution aimed at creating a global preventive screening movement.
Why Papeasy
We believe that when women everywhere are given access to the right tools to protect their health, lives can be saved. PapEasy was created from this conviction-both a movement and a medical innovation centered around a slender, flexible wand equipped with a microscopic, advanced imaging camera. Our mission is to design intuitive self-screening solutions for common gynecological tests, delivering meaningful improvements in technology and user experience while advancing OB-GYN care into the modern era.
Fast & Reliable Service
Delivering consistent screening support designed for speed, accuracy, and dependable outcomes when it matters most.
Patient-Oriented
Placing women at the center of care by prioritizing comfort, dignity, privacy, and ease of use throughout the experience.
Global Accessibility
Expanding access to cervical screening solutions across diverse regions, including underserved and resource-limited communities worldwide.
Educational Programs
Supporting awareness and understanding through structured initiatives that help women make informed decisions about preventive health.
Our Team
Our team was built with our customers and our vision in mind. We are composed of proven leaders in our respective industries and are passionate about bringing our specific skills to a project that can impact billions of women around the world.
Kamran Ayagh
CEO & Founder With over 15 years of experience in healthcare innovation, currently leading PapEasy Inc. as CEO, specializing in medical devices for cervical cancer prescreening. Focused on advancing preventive medical solutions, leveraging expertise in wellness and personalized testing to address critical health challenges. Dedicated to fostering accessible, patient-centered care that aligns with organizational missions to improve lives through technology and innovation. Preview modal-
Kamran’s background and travels have given him a very personal motivation to address the global inequalities and struggles that women endure fighting for access to healthcare, government, and basic human rights..
As the founder and CEO of Quest Active Care, a functional medicine facility that focused on health and wellness through scientific testing and preventative medicine, Kamran (and Quest) have achieved sustained market leadership with national and international expansion in progress. Serving a audience of women in a patient-centric practice has given Kamran a unique perspective into not just women’s health, but their attitudes and opinions about preventative health.
After numerous personal losses to cervical cancer, Kamran, designed PapEasy. Armed with the knowledge that cervical cancer is preventable with earlier, easier, and more affordable access to screening, PapEasy is the heart of Kamran’s vision is to conquer the global cervical cancer crisis by eliminating barriers to Pap Smears and putting lifesaving power into the hands of women, one test at a time. With PapEasy Kamran has created a visionary approach that will use technology to stop cervical cancer before it can start.
Karen Yeates, MD, MPH
Chief Scientific Officer (CSO)
Dr. Karen Yeates is the lead R&D scientist at PapEasy and a physician-scientist, global health researcher, and professor at Queen’s University. Her work focuses on advancing cervical cancer screening and early detection through innovative research, HPV-based screening, self-sampling, and mobile health solutions that improve access for women in underserved communities.
Julie Ann Francis, MD
Chief Medical Officer (CMO)
Dr. Julie Ann Francis is an Obstetrician-Gynecologist and gynecologic oncology specialist based in Kingston, Ontario. She earned her MD from Yale University in 2000, is licensed in Obstetrics and Gynecology in Ontario, and has held roles with Queen’s University and Kingston’s gynecologic oncology community. Her work has included leadership in colposcopy and women’s cancer care, bringing deep clinical expertise to PapEasy’s mission to improve cervical cancer screening for women.
Carlos Conde
PhD – CTEO Medical Device Technology Scientist in charge of the PapEasy product, regulatory, and technology line’s development and enhancement. He holds a Ph.D. in physical chemistry from the University of Puerto Rico Preview modal-and has extensive expertise in the medical and pharmaceutical industries, including designing, leading, and introducing innovative products and procedures.
Gabriel Levin, MD
Chief Oncology Research Officer (CORO)
Dr. Gabriel Levin is a gynecologic oncologist and clinician-scientist at the McGill University Health Centre in Montreal, Canada. He specializes in women’s cancers, translational oncology research, and advancing innovative approaches to early detection and access to gynecologic care.
Our Collaborations & Sponsors
